Agios Pharmaceuticals Inc. buy BiotechBee
Start price
24.11.25
/
70%
€23.00
Target price
31.03.28
€30.00
Performance (%)
27.83%
End price
19.04.26
€29.40
Summary
This prediction ended on 19.04.26 with a price of €29.40. The prediction had a final performance of 27.83%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Agios Pharmaceuticals Inc. | -1.667% | -1.667% |
| iShares Core DAX® | 0,22 % | 1,49 % |
| iShares Nasdaq 100 | 6,05 % | 16,19 % |
| iShares Nikkei 225® | 5,72 % | 11,69 % |
| iShares S&P 500 | 2,17 % | 8,06 % |
According to BiotechBee what are the pros and cons of Agios Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 30,0
In the thread Trading Agios Pharmaceuticals Inc.
Buy beendet
Stopped prediction by BiotechBee for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€20.60
10.12.23
10.12.23
€26.00
30.11.25
30.11.25
81.55%
14.12.24
14.12.24
Could be very worthwhile Investment >20% year

